There are 51 resources available
LBA70 - OSIRAM-1: A multicenter, open label, randomized phase II study of osimertinib plus ramucirumab versus osimertinib alone as initial chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer (TORG1833)
Presenter: Yoshiro Nakahara
Session: Mini oral session 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
1022MO - Predicting overall survival of patients with melanoma and NSCLC treated with immunotherapy using AI combining total tumor volume and tumor heterogeneity on CT-Scans
Presenter: Lama Dawi
Session: Mini oral session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1263MO - The impact of PET-CT and brain MRI for metastasis detection among patients with T1-stage lung cancer: Findings from a large cohort study
Presenter: Wenhua Liang
Session: Mini oral session 1 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA93 - EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC)
Presenter: Ying Liu
Session: Mini oral session 1 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1292MO - A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (≧75 years): NEJ039A
Presenter: Ryo Ko
Session: Mini oral session 2 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
661MO - Anti-tumor activity of belvarafenib in combination with cobimetinib in patients with metastatic solid tumors harboring BRAF fusions or BRAF class II/III mutation
Presenter: Tae Won Kim
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
2032MO - Correlation of safety and efficacy in atezolizumab therapy across indications
Presenter: Jarushka Naidoo
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1322MO - Insights into tumour dissemination and progression using longitudinal Imaging and ctDNA in the TRACERx lung cancer study
Presenter: Wing Kin Liu
Session: Mini oral session 2 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
1988MO - Recruitment discontinuation in TREASURE trial (thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease) due to unexpected safety data
Presenter: Farastuk Bozorgmehr
Session: Mini oral session 1 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1990MO - Sacituzumab govitecan (SG) as second-line (2L) treatment for extensive stage small cell lung cancer (ES-SCLC): Preliminary results from the phase II TROPiCS-03 basket trial
Presenter: Afshin Dowlati
Session: Mini oral session 1 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast